How accurately do we measure blood glucose levels in intensive care unit (ICU) patients?

Best Practice & Research. Clinical Anaesthesiology
Hans Günther Wahl

Abstract

Hyperglycaemia is commonly found in critically ill patients as a result of numerous processes such as increased gluconeogenesis and glycogenolysis caused by elevated levels of corresponding hormones and insulin resistance. As the clinical consequence of hyperglycaemia has been shown to increase morbidity and mortality in various clinical settings, many hospitals by now use tight glycaemic control protocols for their patients in intensive care units to maintain normoglycaemia. The success of the intensive insulin therapy depends crucially on frequent and accurate blood glucose measurements with immediate feedback of results. Therefore, in almost all cases, this will be done by point-of-care testing methods, raising the question of how accurately blood glucose levels are actually measured and what devices should be used. This review focusses on glucose assay principles, specimen matrices, influences and interferences of glucose measurements and finally looks at the numerous evaluation reports on point-of-care glucose testing devices.

References

Mar 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·J M Burrin, K G Alberti
Jul 1, 1990·Clinica Chimica Acta; International Journal of Clinical Chemistry·N Fogh-AndersenO Siggaard-Andersen
May 1, 1974·Diabetes·A M AlbisserW Zingg
Jan 1, 1995·Annals of Clinical Biochemistry·K Wiener
Feb 1, 1995·American Journal of Clinical Pathology·P M Rainey, P Jatlow
Jan 1, 1993·Annals of Clinical Biochemistry·K Wiener
Jul 15, 1996·Clinica Chimica Acta; International Journal of Clinical Chemistry·V Marks
Jan 13, 2000·American Journal of Clinical Pathology·Z TangG J Kost
May 23, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·K KuwaM Tominaga
May 23, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·R W BurnettUNKNOWN Scientific Division, Working Group on Selective Electrodes
Jul 27, 2001·Diabetes Technology & Therapeutics·Z TangG J Kost
Jul 27, 2001·Diabetes Technology & Therapeutics·J J Mastrototaro
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Jan 1, 2003·Clinical Chemistry·Patrick M BossuytUNKNOWN Standards for Reporting of Diagnostic Accuracy
Sep 27, 2003·Diabetes Technology & Therapeutics·Volker LodwigUNKNOWN Glucose Monitoring Study Group
Nov 6, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Christopher P Price
Nov 6, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Robbert J Slingerland, Kor Miedema
Nov 6, 2003·Clinical Chemistry and Laboratory Medicine : CCLM·Lone G M JørgensenMarta Stahl
Nov 25, 2003·Diabetes Technology & Therapeutics·Ellen T ChenGlen Hortin
Dec 1, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·F NobelsP Van Crombrugge
Mar 1, 2005·Emergency Medicine Journal : EMJ·R BoydP Stuart
May 13, 2005·Chest·Javier Daniel FinkielmanBekele Afessa
Jun 7, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Lokinendi V RaoMichael L Snyder
Jul 16, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hubert W VesperGary L Myers
Aug 27, 2005·Clinical Chemistry·Paul D'OrazioUNKNOWN International Federation of Clinical Chemistry Scientific Division Working Group on Selective Electrodes and Point of Care T
Feb 3, 2006·The New England Journal of Medicine·Greet Van den BergheRoger Bouillon
May 16, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Reto SavocaAndreas R Huber
Jun 17, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Michael WehmeierWolf R Külpmann
Jun 28, 2006·Diabetes Technology & Therapeutics·John M BaumChristopher P Price
Sep 20, 2006·Critical Care : the Official Journal of the Critical Care Forum·Anouk M CorstjensJan G Zijlstra
Nov 2, 2006·Current Medical Research and Opinion·Darius Arabadjief, James H Nichols
Nov 9, 2006·Archives of Pathology & Laboratory Medicine·Adil I KhanMartin H Kroll
Dec 16, 2006·Critical Care : the Official Journal of the Critical Care Forum·Frank M Brunkhorst, Hans G Wahl
Dec 29, 2006·Diabetes Care·Darrell M WilsonUNKNOWN DirecNet Study Group

❮ Previous
Next ❯

Citations

Aug 19, 2011·Neurocritical Care·Erich SchmutzhardUNKNOWN Participants in the International Multi-Disciplinary Consensus Conference on the Critical care Management of Subarachnoid He
Nov 15, 2011·International Journal of Cardiology·Mabrouk BahloulMounir Bouaziz
Sep 17, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Philip GoldwasserRobert H Barth
Mar 10, 2012·Journal of Diabetes Science and Technology·Tom Van Herpe, Dieter Mesotten
Aug 7, 2010·Current Opinion in Anaesthesiology·Federico Bilotta, Giovanni Rosa
May 6, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Carmine GreeneBrian Pflug
Oct 31, 2014·Journal of Diabetes Science and Technology·Rajesh Rajendran, Gerry Rayman
Jul 10, 2019·Journal of Diabetes Science and Technology·Kylie PilackasChris Carter
Mar 16, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Koen PoesenFlorent Vanstapel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.